Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs
- 1 October 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (20) , 1753-1760
- https://doi.org/10.1038/sj.gt.3301282
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 31 references indexed in Scilit:
- Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexesGene Therapy, 2000
- Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic AdministrationHuman Gene Therapy, 1998
- Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 1998
- ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivoGene Therapy, 1997
- Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.Journal of Clinical Investigation, 1997
- Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteersGene Therapy, 1997
- Improved DNA: liposome complexes for increased systemic delivery and gene expressionNature Biotechnology, 1997
- Surfactant Inhibits Cationic Liposome-Mediated Gene TransferHuman Gene Therapy, 1997
- Optimization of Formulations and Conditions for the Aerosol Delivery of Functional Cationic Lipid:DNA ComplexesHuman Gene Therapy, 1997
- Factors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNature Biotechnology, 1997